|
Analogs
-
5430822
-
-
5430826
-
-
6091415
-
-
16941331
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50587-5-O |
Homo Sapiens (cluster #5 Of 9), Other |
Other |
94 |
0.58 |
Functional ≤ 10μM
|
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
10000 |
0.41 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
7500 |
0.42 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
6400 |
0.43 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
9320 |
0.41 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
1010 |
0.49 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
5290 |
0.43 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7400 |
0.42 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
8490 |
0.42 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
5200 |
0.44 |
Functional ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
850 |
0.50 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
2200 |
0.47 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
8200 |
0.42 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
5700 |
0.43 |
Functional ≤ 10μM
|
Z81166-1-O |
LLC Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.48 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
4760 |
0.44 |
Functional ≤ 10μM
|
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 4), Other |
Other |
1840 |
0.47 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
890 |
0.50 |
ADME/T ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
5290 |
0.43 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6390 |
0.43 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
850 |
0.50 |
ADME/T ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 2), Other |
Other |
510 |
0.52 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
4760 |
0.44 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-1.52 |
-8.8 |
-12.79 |
5 |
7 |
0 |
126 |
260.271 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
FNTA-1-E |
Protein Farnesyltransferase/geranylgeranyltransferase Type I Alpha Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.40 |
Binding ≤ 10μM
|
FNTB-1-E |
Protein Farnesyltransferase Beta Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.40 |
Binding ≤ 10μM
|
ILVB-1-F |
Acetolactate Synthase Catalytic Subunit, Mitochondrial (cluster #1 Of 1), Fungal |
Fungi |
200 |
0.45 |
Binding ≤ 10μM
|
Z50420-2-O |
Trypanosoma Brucei Brucei (cluster #2 Of 7), Other |
Other |
10 |
0.53 |
Functional ≤ 10μM
|
Z50426-6-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #6 Of 9), Other |
Other |
3600 |
0.36 |
Functional ≤ 10μM
|
Z50442-2-O |
Candida Albicans (cluster #2 Of 4), Other |
Other |
3100 |
0.37 |
Functional ≤ 10μM
|
Z50476-1-O |
Tetrahymena Pyriformis (cluster #1 Of 1), Other |
Other |
380 |
0.43 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3 |
0.57 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
150 |
0.45 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
2450 |
0.37 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 5), Other |
Other |
123 |
0.46 |
ADME/T ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.40 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.47 |
1.87 |
-13.46 |
2 |
6 |
0 |
81 |
326.399 |
1 |
↓
|
|
|
Analogs
-
4212843
-
-
607790
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 53 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-2-E |
Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
Q862L2-2-E |
Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2500 |
0.27 |
Binding ≤ 10μM |
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2700 |
0.27 |
Binding ≤ 10μM
|
TBB-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1260 |
0.28 |
Binding ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Binding ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.29 |
Binding ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.30 |
Binding ≤ 10μM
|
TBG1-1-E |
Tubulin Gamma-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5750 |
0.25 |
Binding ≤ 10μM
|
Q862F3-1-E |
Tubulin Alpha Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
Q862L2-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBA4A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1700 |
0.28 |
Functional ≤ 10μM
|
TBB1-1-E |
Tubulin Beta-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
800 |
0.29 |
Functional ≤ 10μM
|
TBB2B-1-E |
Tubulin Beta Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8700 |
0.24 |
Functional ≤ 10μM
|
TBB3-1-E |
Tubulin Beta-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4A-1-E |
Tubulin Beta-4 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB4B-1-E |
Tubulin Beta-2 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
TBB5-1-E |
Tubulin Beta-5 Chain (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3300 |
0.26 |
Functional ≤ 10μM
|
TBB8-1-E |
Tubulin Beta-8 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4200 |
0.26 |
Functional ≤ 10μM
|
Z101682-1-O |
BK Polyomavirus (cluster #1 Of 2), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.24 |
Functional ≤ 10μM
|
Z50590-1-O |
Sus Scrofa (cluster #1 Of 1), Other |
Other |
1400 |
0.28 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
18 |
0.37 |
Functional ≤ 10μM |
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
12 |
0.38 |
Functional ≤ 10μM
|
Z80024-1-O |
A9 (Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
31 |
0.36 |
Functional ≤ 10μM
|
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
220 |
0.32 |
Functional ≤ 10μM |
Z80096-1-O |
CHO-TAX 5-6 (cluster #1 Of 2), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM |
Z80097-1-O |
CHO-VV 3-2 (cluster #1 Of 2), Other |
Other |
620 |
0.30 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
190 |
0.32 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
53 |
0.35 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
1 |
0.43 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
22 |
0.37 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1900 |
0.28 |
Functional ≤ 10μM |
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
15 |
0.38 |
Functional ≤ 10μM
|
Z80354-1-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
800 |
0.29 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
10 |
0.39 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
33 |
0.36 |
Functional ≤ 10μM |
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM
|
Z80427-1-O |
RKO (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
71 |
0.35 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
30 |
0.36 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.40 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
390 |
0.31 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
45 |
0.35 |
Functional ≤ 10μM
|
Z80711-1-O |
NCI/ADR-RES (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
1113 |
0.29 |
Functional ≤ 10μM |
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
9 |
0.39 |
Functional ≤ 10μM
|
Z80720-1-O |
Burkitts Lymphoma Cells (cluster #1 Of 1), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
52 |
0.35 |
Functional ≤ 10μM |
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
3 |
0.41 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
8 |
0.39 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
40 |
0.36 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM |
Z81054-2-O |
SF-268 (Glioblastoma Cells) (cluster #2 Of 3), Other |
Other |
50 |
0.35 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
17 |
0.38 |
Functional ≤ 10μM |
Z81115-1-O |
KB (Squamous Cell Carcinoma) (cluster #1 Of 6), Other |
Other |
6 |
0.40 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
20 |
0.37 |
Functional ≤ 10μM |
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
93 |
0.34 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
7 |
0.39 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
39 |
0.36 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.35 |
Functional ≤ 10μM
|
Z81281-1-O |
NCI-H23 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 5), Other |
Other |
13 |
0.38 |
Functional ≤ 10μM |
Z81283-1-O |
NCI-H522 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
14 |
0.38 |
Functional ≤ 10μM |
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
140 |
0.33 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
530 |
0.30 |
ADME/T ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
522 |
0.30 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.39 |
ADME/T ≤ 10μM |
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
3 |
0.41 |
ADME/T ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 3), Other |
Other |
210 |
0.32 |
ADME/T ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
2 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.10 |
7.99 |
-20.74 |
1 |
7 |
0 |
83 |
399.443 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNA2-1-E |
Cyclin A2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
355 |
0.27 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1904 |
0.24 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.35 |
Binding ≤ 10μM
|
PLK2-1-E |
Serine/threonine-protein Kinase PLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
238 |
0.28 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
450 |
0.27 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
587 |
0.26 |
Binding ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
219 |
0.28 |
Binding ≤ 10μM
|
Z104296-1-O |
Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other |
Other |
160 |
0.29 |
Binding ≤ 10μM
|
Z104299-1-O |
Cyclin-dependent Kinase 2/cyclin E1 (cluster #1 Of 1), Other |
Other |
347 |
0.27 |
Binding ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
10 |
0.34 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
78 |
0.30 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
44 |
0.31 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
25 |
0.32 |
Functional ≤ 10μM
|
Z80942-1-O |
HEL (Embryonic Lung Cells) (cluster #1 Of 2), Other |
Other |
5 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
9 |
0.34 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
8 |
0.34 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
73 |
0.30 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.49 |
7.93 |
-49.42 |
4 |
10 |
1 |
116 |
449.539 |
5 |
↓
|
|
|
Analogs
-
13361676
-
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.85 |
11.85 |
-12.99 |
1 |
6 |
0 |
66 |
401.466 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
180 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.37 |
10.97 |
-14.35 |
1 |
7 |
0 |
75 |
471.435 |
8 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.30 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
530 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.08 |
1.15 |
-12.72 |
1 |
6 |
0 |
65 |
421.884 |
6 |
↓
|
|
|
Analogs
-
34858628
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.28 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2600 |
0.25 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
6.22 |
2.23 |
-13.05 |
1 |
6 |
0 |
65 |
415.493 |
6 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 15 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
56 |
0.41 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.41 |
Binding ≤ 10μM
|
CSK21-1-E |
Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1 |
0.50 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
17 |
0.44 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
55 |
0.41 |
Binding ≤ 10μM
|
HIPK3-1-E |
Homeodomain-interacting Protein Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.41 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
46 |
0.41 |
Binding ≤ 10μM
|
TBK1-1-E |
Serine/threonine-protein Kinase TBK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.42 |
Binding ≤ 10μM
|
Z103203-2-O |
A375 (cluster #2 Of 3), Other |
Other |
3900 |
0.30 |
Functional ≤ 10μM
|
Z80186-6-O |
K562 (Erythroleukemia Cells) (cluster #6 Of 11), Other |
Other |
5300 |
0.30 |
Functional ≤ 10μM
|
Z80224-5-O |
MCF7 (Breast Carcinoma Cells) (cluster #5 Of 14), Other |
Other |
8900 |
0.28 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
2100 |
0.32 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
3000 |
0.31 |
Functional ≤ 10μM
|
Z80928-5-O |
HCT-116 (Colon Carcinoma Cells) (cluster #5 Of 9), Other |
Other |
2200 |
0.32 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2500 |
0.31 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
4700 |
0.30 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
6400 |
0.29 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
5.14 |
10.5 |
-55.54 |
1 |
5 |
-1 |
78 |
348.769 |
3 |
↓
|
Hi
High (pH 8-9.5)
|
1.84 |
5.03 |
-92.09 |
7 |
8 |
2 |
122 |
456.497 |
5 |
↓
|
|
|
Analogs
-
4073970
-
-
4536598
-
-
8579261
-
-
11592912
-
-
11592913
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 38 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
FKB1A-1-E |
FK506-binding Protein 1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3600 |
0.38 |
Binding ≤ 10μM
|
Z50347-2-O |
Saccharomyces Cerevisiae (cluster #2 Of 3), Other |
Other |
88 |
0.49 |
Functional ≤ 10μM
|
Z50425-4-O |
Plasmodium Falciparum (cluster #4 Of 22), Other |
Other |
200 |
0.47 |
Functional ≤ 10μM
|
Z50466-5-O |
Trypanosoma Cruzi (cluster #5 Of 8), Other |
Other |
400 |
0.45 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
930 |
0.42 |
Functional ≤ 10μM
|
Z50592-3-O |
Oryctolagus Cuniculus (cluster #3 Of 8), Other |
Other |
5000 |
0.37 |
Functional ≤ 10μM
|
Z80026-2-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
3600 |
0.38 |
Functional ≤ 10μM |
Z80224-6-O |
MCF7 (Breast Carcinoma Cells) (cluster #6 Of 14), Other |
Other |
1500 |
0.41 |
Functional ≤ 10μM
|
Z80390-3-O |
PC-3 (Prostate Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
3500 |
0.38 |
Functional ≤ 10μM
|
Z80485-2-O |
SK-MEL-28 (Melanoma Cells) (cluster #2 Of 6), Other |
Other |
1000 |
0.42 |
Functional ≤ 10μM
|
Z80490-1-O |
SK-MES-1 (cluster #1 Of 4), Other |
Other |
2700 |
0.39 |
Functional ≤ 10μM
|
Z80583-3-O |
Vero (Kidney Cells) (cluster #3 Of 7), Other |
Other |
530 |
0.44 |
Functional ≤ 10μM
|
Z80653-1-O |
9L (Glioma Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.47 |
Functional ≤ 10μM
|
Z80874-4-O |
CEM (T-cell Leukemia) (cluster #4 Of 7), Other |
Other |
80 |
0.50 |
Functional ≤ 10μM
|
Z81020-4-O |
HepG2 (Hepatoblastoma Cells) (cluster #4 Of 8), Other |
Other |
2500 |
0.39 |
Functional ≤ 10μM
|
Z81072-7-O |
Jurkat (Acute Leukemic T-cells) (cluster #7 Of 10), Other |
Other |
930 |
0.42 |
Functional ≤ 10μM
|
Z81170-3-O |
LNCaP (Prostate Carcinoma) (cluster #3 Of 5), Other |
Other |
1200 |
0.41 |
Functional ≤ 10μM
|
Z81247-6-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #6 Of 9), Other |
Other |
533 |
0.44 |
Functional ≤ 10μM
|
Z81252-4-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #4 Of 11), Other |
Other |
1200 |
0.41 |
Functional ≤ 10μM |
Z80005-2-O |
3T3 (Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
912 |
0.42 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.76 |
3.22 |
-17 |
2 |
5 |
0 |
83 |
281.352 |
3 |
↓
|
|
|
Analogs
-
14087743
-
-
38139357
-
-
43562168
-
-
44404231
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z101870-1-O |
Leishmania Guyanensis (cluster #1 Of 2), Other |
Other |
9500 |
0.26 |
Functional ≤ 10μM
|
Z50417-1-O |
Leishmania Infantum (cluster #1 Of 4), Other |
Other |
6700 |
0.27 |
Functional ≤ 10μM
|
Z50457-3-O |
Leishmania Amazonensis (cluster #3 Of 3), Other |
Other |
3120 |
0.29 |
Functional ≤ 10μM
|
Z50458-2-O |
Leishmania Braziliensis (cluster #2 Of 4), Other |
Other |
9000 |
0.26 |
Functional ≤ 10μM
|
Z50459-4-O |
Leishmania Donovani (cluster #4 Of 8), Other |
Other |
8720 |
0.26 |
Functional ≤ 10μM
|
Z80166-9-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #9 Of 12), Other |
Other |
6150 |
0.27 |
Functional ≤ 10μM
|
Z80255-1-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
5350 |
0.27 |
Functional ≤ 10μM
|
Z81024-4-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #4 Of 8), Other |
Other |
6620 |
0.27 |
Functional ≤ 10μM
|
Z81072-3-O |
Jurkat (Acute Leukemic T-cells) (cluster #3 Of 10), Other |
Other |
10000 |
0.26 |
Functional ≤ 10μM
|
Z81245-2-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
5000 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.84 |
5.27 |
-48.07 |
0 |
5 |
0 |
58 |
407.576 |
20 |
↓
|
|
|
Analogs
-
43562168
-
-
44404231
-
-
8214614
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z101870-1-O |
Leishmania Guyanensis (cluster #1 Of 2), Other |
Other |
9500 |
0.26 |
Functional ≤ 10μM
|
Z50417-1-O |
Leishmania Infantum (cluster #1 Of 4), Other |
Other |
6700 |
0.27 |
Functional ≤ 10μM
|
Z50457-3-O |
Leishmania Amazonensis (cluster #3 Of 3), Other |
Other |
3120 |
0.29 |
Functional ≤ 10μM
|
Z50458-2-O |
Leishmania Braziliensis (cluster #2 Of 4), Other |
Other |
9000 |
0.26 |
Functional ≤ 10μM
|
Z50459-4-O |
Leishmania Donovani (cluster #4 Of 8), Other |
Other |
8720 |
0.26 |
Functional ≤ 10μM
|
Z80166-9-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #9 Of 12), Other |
Other |
6150 |
0.27 |
Functional ≤ 10μM
|
Z80255-1-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
5350 |
0.27 |
Functional ≤ 10μM
|
Z81024-4-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #4 Of 8), Other |
Other |
6620 |
0.27 |
Functional ≤ 10μM
|
Z81072-3-O |
Jurkat (Acute Leukemic T-cells) (cluster #3 Of 10), Other |
Other |
10000 |
0.26 |
Functional ≤ 10μM
|
Z81245-2-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
5000 |
0.27 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.84 |
16.88 |
-47.16 |
0 |
5 |
0 |
59 |
407.576 |
20 |
↓
|
|
|
Analogs
-
3978074
-
-
4245659
-
-
4245660
-
-
4467870
-
-
11592709
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 37 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
KITH-1-E |
Thymidine Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7000 |
0.38 |
Binding ≤ 10μM
|
CXCR4-1-E |
C-X-C Chemokine Receptor Type 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.60 |
Functional ≤ 10μM
|
Z80295-1-O |
MT4 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
4 |
0.62 |
Functional ≤ 10μM
|
Z102020-1-O |
Porcine Endogenous Retrovirus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50459-2-O |
Leishmania Donovani (cluster #2 Of 8), Other |
Other |
3400 |
0.40 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
7 |
0.60 |
Functional ≤ 10μM
|
Z50594-1-O |
Mus Musculus (cluster #1 Of 9), Other |
Other |
46 |
0.54 |
Functional ≤ 10μM
|
Z50607-1-O |
Human Immunodeficiency Virus 1 (cluster #1 Of 10), Other |
Other |
9600 |
0.37 |
Functional ≤ 10μM
|
Z50609-1-O |
Simian Immunodeficiency Virus (cluster #1 Of 2), Other |
Other |
12 |
0.58 |
Functional ≤ 10μM
|
Z50658-1-O |
Human Immunodeficiency Virus 2 (cluster #1 Of 4), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50664-1-O |
Rauscher Murine Leukemia Virus (cluster #1 Of 1), Other |
Other |
23 |
0.56 |
Functional ≤ 10μM
|
Z50677-1-O |
Human Immunodeficiency Virus (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z50737-1-O |
Human Immunodeficiency Virus 3 (cluster #1 Of 1), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80071-1-O |
CEM-0 (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80073-1-O |
CEM-c113 (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80076-1-O |
CEM-SS (T-cell Leukemia) (cluster #1 Of 5), Other |
Other |
95 |
0.52 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
6180 |
0.38 |
Functional ≤ 10μM
|
Z80285-1-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #1 Of 4), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80294-1-O |
MT2 (Lymphocytes) (cluster #1 Of 1), Other |
Other |
6 |
0.61 |
Functional ≤ 10μM
|
Z80295-2-O |
MT4 (Lymphocytes) (cluster #2 Of 8), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z80384-1-O |
PBL (Peripheral Blood Lymphocytes) (cluster #1 Of 1), Other |
Other |
29 |
0.56 |
Functional ≤ 10μM
|
Z80516-1-O |
SUP-T1 (cluster #1 Of 1), Other |
Other |
50 |
0.54 |
Functional ≤ 10μM |
Z80566-1-O |
U-937 (Histiocytic Lymphoma Cells) (cluster #1 Of 2), Other |
Other |
40 |
0.55 |
Functional ≤ 10μM
|
Z80683-1-O |
ATH8 Cell Line (cluster #1 Of 1), Other |
Other |
400 |
0.47 |
Functional ≤ 10μM
|
Z80688-1-O |
B(EBV+) Cell Line (cluster #1 Of 1), Other |
Other |
1 |
0.66 |
Functional ≤ 10μM
|
Z80721-1-O |
BxT Cell Line (cluster #1 Of 1), Other |
Other |
55 |
0.53 |
Functional ≤ 10μM
|
Z80737-1-O |
C3H/3T3 (Embryonic Fibroblast Cells) (cluster #1 Of 1), Other |
Other |
20 |
0.57 |
Functional ≤ 10μM
|
Z80760-1-O |
CFU-GM Cell Line (cluster #1 Of 1), Other |
Other |
1500 |
0.43 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
870 |
0.45 |
Functional ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM |
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
10 |
0.59 |
Functional ≤ 10μM
|
Z81223-1-O |
M Cell Line (cluster #1 Of 1), Other |
Other |
15 |
0.58 |
Functional ≤ 10μM
|
Z81247-7-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #7 Of 9), Other |
Other |
9 |
0.59 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 4), Other |
Other |
700 |
0.45 |
ADME/T ≤ 10μM
|
Z80897-1-O |
H9 (T-lymphoid Cells) (cluster #1 Of 2), Other |
Other |
45 |
0.54 |
ADME/T ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 6), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72874-1-V |
Human Immunodeficiency Virus Type 1 Protease (cluster #1 Of 3), Viral |
Viruses |
6 |
0.61 |
Binding ≤ 10μM
|
Q72547-1-V |
Human Immunodeficiency Virus Type 1 Reverse Transcriptase (cluster #1 Of 1), Viral |
Viruses |
8 |
0.60 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
-0.10 |
-3.76 |
-14.65 |
2 |
9 |
0 |
134 |
267.245 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
IKKA-2-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1300 |
0.32 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Binding ≤ 10μM
|
TF65-1-E |
Nuclear Factor NF-kappa-B P65 Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
380 |
0.35 |
Binding ≤ 10μM
|
FOS-1-E |
Proto-oncogene Protein C-fos (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Functional ≤ 10μM
|
JUN-1-E |
Proto-oncogene C-JUN (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Functional ≤ 10μM
|
NFKB1-1-E |
Nuclear Factor NF-kappa-B P105 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Functional ≤ 10μM
|
NFKB2-1-E |
Nuclear Factor NF-kappa-B P100/p49 Subunits (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Functional ≤ 10μM
|
TF65-1-E |
Nuclear Factor NF-kappa-B P65 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
8 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.25 |
7.83 |
-20.46 |
1 |
7 |
0 |
86 |
366.402 |
4 |
↓
|
|
|
Analogs
-
4095791
-
-
12501465
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AAK1-1-E |
Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
AAPK1-1-E |
AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
AAPK2-1-E |
AMP-activated Protein Kinase, Alpha-2 Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
12 |
0.32 |
Binding ≤ 10μM
|
ABL1-1-E |
Tyrosine-protein Kinase ABL (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
91 |
0.28 |
Binding ≤ 10μM
|
ABL2-1-E |
Tyrosine-protein Kinase ABL2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.27 |
Binding ≤ 10μM
|
ACK1-1-E |
Tyrosine Kinase Non-receptor Protein 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
ACV1B-1-E |
Activin Receptor Type-1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
680 |
0.25 |
Binding ≤ 10μM
|
ACVR1-1-E |
Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.25 |
Binding ≤ 10μM
|
AKT1-2-E |
RAC-alpha Serine/threonine-protein Kinase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
AKT2-2-E |
Serine/threonine-protein Kinase AKT2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
AKT3-2-E |
Serine/threonine-protein Kinase AKT3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
ALK-1-E |
ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
ANKK1-1-E |
Ankyrin Repeat And Protein Kinase Domain-containing Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
22 |
0.31 |
Binding ≤ 10μM
|
AURKB-1-E |
Serine/threonine-protein Kinase Aurora-B (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
AURKC-1-E |
Serine/threonine-protein Kinase Aurora-C (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
AVR2B-1-E |
Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4600 |
0.21 |
Binding ≤ 10μM
|
BLK-1-E |
Tyrosine-protein Kinase BLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
15 |
0.31 |
Binding ≤ 10μM
|
BMP2K-1-E |
BMP-2-inducible Protein Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
BMR1A-1-E |
Bone Morphogenetic Protein Receptor Type-1A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3700 |
0.22 |
Binding ≤ 10μM
|
BMX-1-E |
Tyrosine-protein Kinase BMX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
410 |
0.26 |
Binding ≤ 10μM
|
BRSK1-1-E |
BR Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
BRSK2-1-E |
BR Serine/threonine-protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
BTK-1-E |
Tyrosine-protein Kinase BTK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.25 |
Binding ≤ 10μM
|
CCNB1-1-E |
G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNB2-1-E |
G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNB3-1-E |
G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
CCNE1-1-E |
G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
CCNE2-1-E |
G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CDK14-1-E |
Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
160 |
0.27 |
Binding ≤ 10μM
|
CDK16-1-E |
Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
25 |
0.30 |
Binding ≤ 10μM
|
CDK17-1-E |
Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
96 |
0.28 |
Binding ≤ 10μM
|
CDK18-1-E |
Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
CDK19-1-E |
Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CDK3-1-E |
Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CDK4-2-E |
Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
18 |
0.31 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
89 |
0.28 |
Binding ≤ 10μM
|
CDK6-1-E |
Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
116 |
0.28 |
Binding ≤ 10μM
|
CDK7-1-E |
Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.29 |
Binding ≤ 10μM
|
CDK8-1-E |
Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
510 |
0.25 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
CHK1-1-E |
Serine/threonine-protein Kinase Chk1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
CHK2-1-E |
Serine/threonine-protein Kinase Chk2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CLK1-2-E |
Dual Specificty Protein Kinase CLK1 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
CLK2-1-E |
Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
CLK3-1-E |
Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.24 |
Binding ≤ 10μM
|
CLK4-1-E |
Dual Specificity Protein Kinase CLK4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
CSF1R-1-E |
Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
12 |
0.32 |
Binding ≤ 10μM
|
CSK-1-E |
Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
440 |
0.25 |
Binding ≤ 10μM
|
CSK21-1-E |
Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7620 |
0.20 |
Binding ≤ 10μM
|
CSK22-1-E |
Casein Kinase II Alpha (prime) (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
CSK2B-1-E |
Casein Kinase II Beta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
7000 |
0.21 |
Binding ≤ 10μM
|
CTRO-1-E |
Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
340 |
0.26 |
Binding ≤ 10μM
|
DAPK1-1-E |
Death-associated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
DAPK2-1-E |
Death-associated Protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
DAPK3-1-E |
Death-associated Protein Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1500 |
0.23 |
Binding ≤ 10μM
|
DCLK1-1-E |
Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.28 |
Binding ≤ 10μM
|
DCLK2-1-E |
Serine/threonine-protein Kinase DCLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
73 |
0.29 |
Binding ≤ 10μM
|
DCLK3-1-E |
Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
DDR1-1-E |
Epithelial Discoidin Domain-containing Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
DDR2-1-E |
Discoidin Domain-containing Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
DMPK-1-E |
Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
DYR1B-1-E |
Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.28 |
Binding ≤ 10μM |
E2AK2-1-E |
Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
360 |
0.26 |
Binding ≤ 10μM
|
E2AK4-1-E |
Eukaryotic Translation Initiation Factor 2-alpha Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
EGFR-1-E |
Epidermal Growth Factor Receptor ErbB1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
96 |
0.28 |
Binding ≤ 10μM
|
EPHA1-1-E |
Ephrin Type-A Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
EPHA2-1-E |
Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
870 |
0.24 |
Binding ≤ 10μM
|
EPHA3-1-E |
Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
55 |
0.29 |
Binding ≤ 10μM
|
EPHA4-1-E |
Ephrin Type-A Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
710 |
0.25 |
Binding ≤ 10μM
|
EPHA5-1-E |
Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
95 |
0.28 |
Binding ≤ 10μM
|
EPHA6-1-E |
Ephrin Type-A Receptor 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
290 |
0.26 |
Binding ≤ 10μM
|
EPHA7-1-E |
Ephrin Type-A Receptor 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.25 |
Binding ≤ 10μM
|
EPHA8-1-E |
Ephrin Type-A Receptor 8 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
EPHB1-1-E |
Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
590 |
0.25 |
Binding ≤ 10μM
|
EPHB2-1-E |
Ephrin Type-B Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2100 |
0.23 |
Binding ≤ 10μM
|
EPHB4-1-E |
Ephrin Type-B Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
233 |
0.27 |
Binding ≤ 10μM
|
ERBB4-1-E |
Receptor Protein-tyrosine Kinase ErbB-4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
282 |
0.26 |
Binding ≤ 10μM
|
FAK1-1-E |
Focal Adhesion Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
68 |
0.29 |
Binding ≤ 10μM
|
FAK2-1-E |
Protein-tyrosine Kinase 2-beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
FER-1-E |
Tyrosine-protein Kinase FER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
FES-1-E |
Tyrosine-protein Kinase FES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
FGFR1-1-E |
Fibroblast Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
90 |
0.28 |
Binding ≤ 10μM
|
FGFR2-1-E |
Fibroblast Growth Factor Receptor 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
FGFR3-1-E |
Fibroblast Growth Factor Receptor 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
88 |
0.28 |
Binding ≤ 10μM
|
FGFR4-1-E |
Fibroblast Growth Factor Receptor 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.26 |
Binding ≤ 10μM
|
FGR-1-E |
Tyrosine-protein Kinase FGR (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
FRK-1-E |
Tyrosine-protein Kinase FRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
45 |
0.29 |
Binding ≤ 10μM
|
FYN-1-E |
Tyrosine-protein Kinase FYN (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
83 |
0.28 |
Binding ≤ 10μM
|
GAK-1-E |
Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
68 |
0.29 |
Binding ≤ 10μM
|
GSK3A-1-E |
Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
140 |
0.27 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
89 |
0.28 |
Binding ≤ 10μM
|
HCK-1-E |
Tyrosine-protein Kinase HCK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
HIPK1-1-E |
Homeodomain-interacting Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2639 |
0.22 |
Binding ≤ 10μM
|
IGF1R-1-E |
Insulin-like Growth Factor 1 Receptor (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
IKKA-2-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Alpha Subunit (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
39 |
0.30 |
Binding ≤ 10μM
|
IKKB-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Beta Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
771 |
0.24 |
Binding ≤ 10μM
|
IKKE-1-E |
Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
INSR-1-E |
Insulin Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.27 |
Binding ≤ 10μM
|
INSRR-1-E |
Insulin Receptor-related Protein (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
81 |
0.28 |
Binding ≤ 10μM
|
IRAK3-1-E |
Interleukin-1 Receptor-associated Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.32 |
Binding ≤ 10μM
|
IRAK4-1-E |
Interleukin-1 Receptor-associated Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
34 |
0.30 |
Binding ≤ 10μM
|
ITK-1-E |
Tyrosine-protein Kinase ITK/TSK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
19 |
0.31 |
Binding ≤ 10μM
|
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
JAK3-1-E |
Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KAP2-1-E |
CAMP-dependent Protein Kinase Type II-alpha Regulatory Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
100 |
0.28 |
Binding ≤ 10μM
|
KAPCA-1-E |
CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
27 |
0.30 |
Binding ≤ 10μM
|
KAPCB-1-E |
CAMP-dependent Protein Kinase Beta-1 Catalytic Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
KAPCG-1-E |
CAMP-dependent Protein Kinase, Gamma Catalytic Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
80 |
0.28 |
Binding ≤ 10μM
|
KC1A-1-E |
Casein Kinase I Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1AL-1-E |
Casein Kinase I Isoform Alpha-like (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
250 |
0.26 |
Binding ≤ 10μM
|
KC1D-1-E |
Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1E-1-E |
Casein Kinase I Epsilon (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1G1-1-E |
Casein Kinase I Gamma 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.23 |
Binding ≤ 10μM
|
KC1G2-1-E |
Casein Kinase I Gamma 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
780 |
0.24 |
Binding ≤ 10μM
|
KCC1A-1-E |
CaM Kinase I Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
KCC1D-1-E |
CaM Kinase I Delta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
KCC1G-1-E |
CaM Kinase I Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
53 |
0.29 |
Binding ≤ 10μM
|
KCC2A-1-E |
CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2B-1-E |
CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2D-1-E |
CaM Kinase II Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC2G-1-E |
CaM Kinase II Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
KCC4-1-E |
CaM Kinase IV (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.30 |
Binding ≤ 10μM
|
KGP1-1-E |
CGMP-dependent Protein Kinase 1 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
32 |
0.30 |
Binding ≤ 10μM
|
KGP2-1-E |
CGMP-dependent Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
KKCC1-1-E |
CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
KKCC2-1-E |
CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
KPB1-1-E |
Phosphorylase Kinase Alpha M Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPB2-1-E |
Phosphorylase Kinase Alpha L Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPBB-1-E |
Phosphorylase Kinase Beta Subunit (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
KPCA-1-E |
Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCD-1-E |
Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCD1-1-E |
Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCD2-1-E |
Serine/threonine-protein Kinase D2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
72 |
0.29 |
Binding ≤ 10μM
|
KPCD3-1-E |
Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCE-1-E |
Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCG-1-E |
Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCI-1-E |
Protein Kinase C Iota (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KPCL-2-E |
Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM |
KPCZ-1-E |
Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM |
KS6A1-1-E |
Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6A2-1-E |
Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
KS6A3-1-E |
Ribosomal Protein S6 Kinase Alpha 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
69 |
0.29 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6A5-1-E |
Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
890 |
0.24 |
Binding ≤ 10μM
|
KS6A6-1-E |
Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6B1-1-E |
Ribosomal Protein S6 Kinase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KS6B2-1-E |
Ribosomal Protein S6 Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM |
KSYK-1-E |
Tyrosine-protein Kinase SYK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
LATS1-1-E |
Serine/threonine-protein Kinase LATS1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
LATS2-1-E |
Serine/threonine-protein Kinase LATS2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
LIMK1-1-E |
LIM Domain Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
690 |
0.25 |
Binding ≤ 10μM
|
LIMK2-1-E |
LIM Domain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9200 |
0.20 |
Binding ≤ 10μM
|
LTK-1-E |
Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
LYN-1-E |
Tyrosine-protein Kinase Lyn (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
M3K10-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
M3K11-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
20 |
0.31 |
Binding ≤ 10μM
|
M3K14-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 14 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.23 |
Binding ≤ 10μM
|
M3K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2200 |
0.23 |
Binding ≤ 10μM
|
M3K5-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
M3K7-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
M3K9-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.32 |
Binding ≤ 10μM
|
M4K1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
M4K3-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
M4K4-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 4 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
24 |
0.30 |
Binding ≤ 10μM
|
M4K5-1-E |
Mitogen-activated Protein Kinase Kinase Kinase Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
MAPK2-1-E |
MAP Kinase-activated Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
880 |
0.24 |
Binding ≤ 10μM
|
MARK1-1-E |
Serine/threonine-protein Kinase MARK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
MARK2-1-E |
MAP/microtubule Affinity-regulating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
MARK3-1-E |
Serine/threonine-protein Kinase C-TAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
MARK4-1-E |
MAP/microtubule Affinity-regulating Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
MELK-1-E |
Maternal Embryonic Leucine Zipper Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
33 |
0.30 |
Binding ≤ 10μM
|
MERTK-1-E |
Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
MET-1-E |
Hepatocyte Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
MINK1-1-E |
Misshapen-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
MK01-1-E |
Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7300 |
0.21 |
Binding ≤ 10μM
|
MK03-1-E |
MAP Kinase ERK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8400 |
0.20 |
Binding ≤ 10μM
|
MK07-1-E |
Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.23 |
Binding ≤ 10μM
|
MK08-1-E |
Mitogen-activated Protein Kinase 8 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
520 |
0.25 |
Binding ≤ 10μM
|
MK09-1-E |
C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.24 |
Binding ≤ 10μM
|
MK10-1-E |
C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
340 |
0.26 |
Binding ≤ 10μM
|
MK11-1-E |
MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK12-1-E |
MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
92 |
0.28 |
Binding ≤ 10μM
|
MK13-1-E |
MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK14-1-E |
MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
MK15-1-E |
Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
170 |
0.27 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
22 |
0.31 |
Binding ≤ 10μM
|
MP2K1-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
670 |
0.25 |
Binding ≤ 10μM
|
MP2K2-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
MP2K3-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.33 |
Binding ≤ 10μM
|
MP2K4-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
70 |
0.29 |
Binding ≤ 10μM
|
MP2K6-1-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
MRCKA-1-E |
Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
57 |
0.29 |
Binding ≤ 10μM
|
MRCKB-1-E |
Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
42 |
0.30 |
Binding ≤ 10μM
|
MRCKG-1-E |
Serine/threonine-protein Kinase MRCK Gamma (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
37 |
0.30 |
Binding ≤ 10μM
|
MST4-1-E |
Serine/threonine-protein Kinase MST4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
140 |
0.27 |
Binding ≤ 10μM
|
MUSK-1-E |
Muscle, Skeletal Receptor Tyrosine Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
86 |
0.28 |
Binding ≤ 10μM
|
MYLK-1-E |
Myosin Light Chain Kinase, Smooth Muscle (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
40 |
0.30 |
Binding ≤ 10μM
|
MYLK2-1-E |
Myosin Light Chain Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
MYLK4-1-E |
Myosin Light Chain Kinase Family Member 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.25 |
Binding ≤ 10μM
|
MYO3A-1-E |
Myosin IIIA (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.25 |
Binding ≤ 10μM
|
MYO3B-1-E |
Myosin-IIIB (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
300 |
0.26 |
Binding ≤ 10μM
|
NEK1-1-E |
Serine/threonine-protein Kinase Nek1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
860 |
0.24 |
Binding ≤ 10μM
|
NEK2-1-E |
Serine/threonine-protein Kinase NEK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
750 |
0.24 |
Binding ≤ 10μM
|
NEK5-1-E |
Serine/threonine-protein Kinase Nek5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
810 |
0.24 |
Binding ≤ 10μM
|
NEK7-1-E |
Serine/threonine-protein Kinase NEK7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4500 |
0.21 |
Binding ≤ 10μM
|
NEK9-1-E |
Serine/threonine-protein Kinase NEK9 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6700 |
0.21 |
Binding ≤ 10μM
|
NLK-1-E |
Serine/threonine Protein Kinase NLK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
220 |
0.27 |
Binding ≤ 10μM
|
NTRK1-1-E |
Nerve Growth Factor Receptor Trk-A (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NTRK2-1-E |
Neurotrophic Tyrosine Kinase Receptor Type 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NTRK3-1-E |
NT-3 Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
17 |
0.31 |
Binding ≤ 10μM
|
NUAK1-1-E |
NUAK Family SNF1-like Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
4 |
0.34 |
Binding ≤ 10μM
|
NUAK2-1-E |
NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
P90584-2-E |
Protein Kinase Pfmrk (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
4000 |
0.22 |
Binding ≤ 10μM
|
PAK1-1-E |
Serine/threonine-protein Kinase PAK 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PAK2-1-E |
Serine/threonine-protein Kinase PAK 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PAK3-1-E |
Serine/threonine-protein Kinase PAK 3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
PAK4-1-E |
Serine/threonine-protein Kinase PAK 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
PAK6-1-E |
Serine/threonine-protein Kinase PAK6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PAK7-1-E |
Serine/threonine-protein Kinase PAK7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PDPK1-1-E |
3-phosphoinositide Dependent Protein Kinase-1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PGFRA-1-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PHKG1-1-E |
Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM |
PHKG2-1-E |
Phosphorylase Kinase Gamma Subunit 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM |
PI42B-1-E |
Phosphatidylinositol-5-phosphate 4-kinase Type-2 Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Binding ≤ 10μM
|
PI51A-1-E |
Phosphatidylinositol-4-phosphate 5-kinase Type-1 Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
43 |
0.29 |
Binding ≤ 10μM
|
PIM1-1-E |
Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.32 |
Binding ≤ 10μM
|
PIM2-1-E |
Serine/threonine-protein Kinase PIM2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
PIM3-1-E |
Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PKN1-1-E |
Protein Kinase N1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PKN2-1-E |
Protein Kinase N2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
190 |
0.27 |
Binding ≤ 10μM
|
PLK2-1-E |
Serine/threonine-protein Kinase PLK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
197 |
0.27 |
Binding ≤ 10μM
|
PLK3-1-E |
Serine/threonine-protein Kinase PLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
910 |
0.24 |
Binding ≤ 10μM
|
PLK4-1-E |
Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
PRKX-1-E |
Serine/threonine-protein Kinase PRKX (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
13 |
0.32 |
Binding ≤ 10μM
|
PTK6-1-E |
Tyrosine-protein Kinase BRK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2300 |
0.23 |
Binding ≤ 10μM
|
Q95J97-1-E |
CAMP-dependent Protein Kinase Alpha-catalytic Subunit (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
80 |
0.28 |
Binding ≤ 10μM
|
RAF1-1-E |
Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
RET-1-E |
Tyrosine-protein Kinase Receptor RET (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
28 |
0.30 |
Binding ≤ 10μM
|
RIOK1-1-E |
Serine/threonine-protein Kinase RIO1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
130 |
0.28 |
Binding ≤ 10μM
|
RIOK3-1-E |
Serine/threonine-protein Kinase RIO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
76 |
0.28 |
Binding ≤ 10μM
|
RIPK2-1-E |
Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5200 |
0.21 |
Binding ≤ 10μM
|
ROCK1-1-E |
Rho-associated Protein Kinase 1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
ROS1-1-E |
Proto-oncogene Tyrosine-protein Kinase ROS (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
30 |
0.30 |
Binding ≤ 10μM
|
SIK1-1-E |
Serine/threonine-protein Kinase SIK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
SIK2-1-E |
Serine/threonine-protein Kinase SIK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1 |
0.36 |
Binding ≤ 10μM
|
SLK-1-E |
Serine/threonine-protein Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
SRC-1-E |
Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
86 |
0.28 |
Binding ≤ 10μM
|
SRMS-1-E |
Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
740 |
0.25 |
Binding ≤ 10μM
|
SRPK1-1-E |
Serine/threonine-protein Kinase SRPK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
SRPK2-1-E |
Serine/threonine-protein Kinase SRPK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
67 |
0.29 |
Binding ≤ 10μM
|
ST17A-1-E |
Serine/threonine-protein Kinase 17A (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
23 |
0.31 |
Binding ≤ 10μM
|
ST17B-1-E |
Serine/threonine-protein Kinase 17B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
26 |
0.30 |
Binding ≤ 10μM
|
ST32B-1-E |
Serine/threonine-protein Kinase 32B (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
98 |
0.28 |
Binding ≤ 10μM
|
ST32C-1-E |
Serine/threonine-protein Kinase 32C (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
310 |
0.26 |
Binding ≤ 10μM
|
ST38L-1-E |
Serine/threonine-protein Kinase 38-like (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Binding ≤ 10μM
|
STK10-1-E |
Serine/threonine-protein Kinase 10 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
STK11-1-E |
Serine/threonine-protein Kinase 11 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
STK16-1-E |
Serine/threonine-protein Kinase 16 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
270 |
0.26 |
Binding ≤ 10μM
|
STK24-1-E |
Serine/threonine-protein Kinase 24 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
120 |
0.28 |
Binding ≤ 10μM
|
STK25-1-E |
Serine/threonine-protein Kinase 25 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
110 |
0.28 |
Binding ≤ 10μM
|
STK3-1-E |
Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
STK33-1-E |
Serine/threonine-protein Kinase 33 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2 |
0.35 |
Binding ≤ 10μM
|
STK36-1-E |
Serine/threonine-protein Kinase 36 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6700 |
0.21 |
Binding ≤ 10μM
|
STK4-1-E |
Serine/threonine-protein Kinase MST1 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
SYK-1-E |
Lysyl-tRNA Synthetase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
9 |
0.32 |
Binding ≤ 10μM
|
TAB1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
35 |
0.30 |
Binding ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-3 Chain (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
770 |
0.24 |
Binding ≤ 10μM
|
TEC-1-E |
Tyrosine-protein Kinase TEC (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.24 |
Binding ≤ 10μM
|
TESK1-1-E |
Dual Specificity Testis-specific Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
320 |
0.26 |
Binding ≤ 10μM
|
TGFR1-1-E |
TGF-beta Receptor Type I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2000 |
0.23 |
Binding ≤ 10μM
|
TIE1-1-E |
Tyrosine-protein Kinase Receptor Tie-1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
65 |
0.29 |
Binding ≤ 10μM
|
TIE2-1-E |
Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
TLK1-1-E |
Serine/threonine-protein Kinase Tousled-like 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
27 |
0.30 |
Binding ≤ 10μM
|
TLK2-1-E |
Serine/threonine-protein Kinase Tousled-like 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
16 |
0.31 |
Binding ≤ 10μM
|
TNI3K-1-E |
Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1000 |
0.24 |
Binding ≤ 10μM
|
TNIK-1-E |
TRAF2- And NCK-interacting Kinase (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
6 |
0.33 |
Binding ≤ 10μM
|
TNK1-1-E |
Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
TSSK1-1-E |
Testis-specific Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
24 |
0.30 |
Binding ≤ 10μM
|
TTK-1-E |
Dual Specificity Protein Kinase TTK (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
61 |
0.29 |
Binding ≤ 10μM
|
TXK-1-E |
Tyrosine-protein Kinase TXK (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
230 |
0.27 |
Binding ≤ 10μM
|
TYK2-1-E |
Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
56 |
0.29 |
Binding ≤ 10μM
|
TYRO3-1-E |
Tyrosine-protein Kinase Receptor TYRO3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
49 |
0.29 |
Binding ≤ 10μM
|
UFO-1-E |
Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
7 |
0.33 |
Binding ≤ 10μM
|
ULK3-1-E |
Serine/threonine-protein Kinase ULK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3 |
0.34 |
Binding ≤ 10μM
|
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
14 |
0.31 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
88 |
0.28 |
Binding ≤ 10μM
|
VGFR3-1-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
14 |
0.31 |
Binding ≤ 10μM
|
WEE1-1-E |
Serine/threonine-protein Kinase WEE1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1600 |
0.23 |
Binding ≤ 10μM
|
YES-1-E |
Tyrosine-protein Kinase YES (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
52 |
0.29 |
Binding ≤ 10μM
|
ZAP70-1-E |
Tyrosine-protein Kinase ZAP-70 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
53 |
0.29 |
Binding ≤ 10μM
|
AKT1-1-E |
Serine/threonine-protein Kinase AKT (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
460 |
0.25 |
Functional ≤ 10μM
|
KPCB-1-E |
Protein Kinase C Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
77 |
0.28 |
Functional ≤ 10μM
|
Z104294-1-O |
Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #1 Of 2), Other |
Other |
10 |
0.32 |
Binding ≤ 10μM
|
Z104295-1-O |
Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other |
Other |
59 |
0.29 |
Binding ≤ 10μM
|
Z100081-2-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #2 Of 4), Other |
Other |
16 |
0.31 |
Functional ≤ 10μM
|
Z100201-1-O |
Splenocytes (Spleen Cells) (cluster #1 Of 1), Other |
Other |
400 |
0.26 |
Functional ≤ 10μM |
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
190 |
0.27 |
Functional ≤ 10μM
|
Z50512-1-O |
Cavia Porcellus (cluster #1 Of 7), Other |
Other |
7500 |
0.20 |
Functional ≤ 10μM |
Z80120-1-O |
DLD-1 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9 |
0.32 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3 |
0.34 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
1 |
0.36 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
50 |
0.29 |
Functional ≤ 10μM
|
Z80800-1-O |
MIA PaCa-2 (Pancreatic Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
370 |
0.26 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6 |
0.33 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
77 |
0.28 |
Functional ≤ 10μM
|
Z81057-1-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #1 Of 4), Other |
Other |
4 |
0.34 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
71 |
0.29 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
0 |
0.00 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.89 |
8.49 |
-39.52 |
3 |
7 |
1 |
74 |
467.549 |
2 |
↓
|
Hi
High (pH 8-9.5)
|
3.89 |
8.85 |
-16.32 |
2 |
7 |
0 |
69 |
466.541 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.38 |
3.85 |
-9.44 |
2 |
6 |
0 |
93 |
322.357 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.38 |
3.9 |
-10.99 |
2 |
6 |
0 |
93 |
322.357 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
3 |
0.31 |
Binding ≤ 10μM |
JAK1-1-E |
Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1017 |
0.22 |
Binding ≤ 10μM |
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2550 |
0.21 |
Binding ≤ 10μM |
JAK3-1-E |
Tyrosine-protein Kinase JAK3 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1294 |
0.22 |
Binding ≤ 10μM |
KPCA-1-E |
Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic |
Eukaryotes |
13 |
0.29 |
Binding ≤ 10μM |
KPCT-1-E |
Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
68 |
0.26 |
Binding ≤ 10μM |
TYK2-1-E |
Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8055 |
0.19 |
Binding ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
689 |
0.23 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.63 |
6.76 |
-17.38 |
3 |
8 |
0 |
109 |
526.515 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
FLT3-1-E |
Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.45 |
Binding ≤ 10μM
|
GSK3A-2-E |
Glycogen Synthase Kinase-3 Alpha (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1900 |
0.31 |
Binding ≤ 10μM
|
KIT-1-E |
Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.43 |
Binding ≤ 10μM
|
M3K7-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Binding ≤ 10μM
|
MK01-1-E |
Mitogen-activated Protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1300 |
0.32 |
Binding ≤ 10μM
|
MK03-1-E |
MAP Kinase ERK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1400 |
0.32 |
Binding ≤ 10μM
|
MP2K1-3-E |
Dual Specificity Mitogen-activated Protein Kinase Kinase 1 (cluster #3 Of 4), Eukaryotic |
Eukaryotes |
2 |
0.47 |
Binding ≤ 10μM
|
PGFRA-2-E |
Platelet-derived Growth Factor Receptor Alpha (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
PGFRB-1-E |
Platelet-derived Growth Factor Receptor Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
41 |
0.40 |
Binding ≤ 10μM
|
TAB1-1-E |
Mitogen-activated Protein Kinase Kinase Kinase 7-interacting Protein 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
8 |
0.44 |
Binding ≤ 10μM
|
TF65-1-E |
Nuclear Factor NF-kappa-B P65 Subunit (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
250 |
0.36 |
Binding ≤ 10μM |
VGFR1-1-E |
Vascular Endothelial Growth Factor Receptor 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
12 |
0.43 |
Binding ≤ 10μM
|
VGFR2-1-E |
Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
0 |
0.00 |
Binding ≤ 10μM
|
VGFR3-2-E |
Vascular Endothelial Growth Factor Receptor 3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
1 |
0.48 |
Binding ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
3600 |
0.29 |
Functional ≤ 10μM |
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
4400 |
0.29 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
3800 |
0.29 |
Functional ≤ 10μM |
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
4900 |
0.29 |
Functional ≤ 10μM |
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
5100 |
0.28 |
Functional ≤ 10μM |
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
5600 |
0.28 |
Functional ≤ 10μM |
Z80548-3-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #3 Of 5), Other |
Other |
11 |
0.43 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
7000 |
0.28 |
Functional ≤ 10μM
|
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
3300 |
0.30 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
5500 |
0.28 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.38 |
2.34 |
-12.73 |
3 |
7 |
0 |
113 |
362.378 |
1 |
↓
|
Ref
Reference (pH 7)
|
1.38 |
1.51 |
-10.41 |
3 |
7 |
0 |
113 |
362.378 |
1 |
↓
|
Hi
High (pH 8-9.5)
|
1.38 |
3.43 |
-52.21 |
2 |
7 |
-1 |
116 |
361.37 |
1 |
↓
|
|
|
Analogs
-
3918087
-
-
3938704
-
-
3995925
-
-
3995927
-
-
3995929
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 2 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1900 |
0.21 |
Binding ≤ 10μM
|
Z50460-3-O |
Leishmania Major (cluster #3 Of 4), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM
|
Z80014-1-O |
A204 (Rhabdomyosarcoma Cells) (cluster #1 Of 1), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
3000 |
0.20 |
Functional ≤ 10μM |
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
63 |
0.27 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
9 |
0.30 |
Functional ≤ 10μM |
Z80060-1-O |
CAPAN-1 (Pancreatic Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80134-1-O |
EVSA-T (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
5 |
0.31 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
400 |
0.24 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
15 |
0.29 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
60 |
0.27 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
36 |
0.27 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
1 |
0.33 |
Functional ≤ 10μM |
Z80335-2-O |
NHDF (cluster #2 Of 2), Other |
Other |
404 |
0.24 |
Functional ≤ 10μM |
Z80342-1-O |
NSCLC (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
4 |
0.31 |
Functional ≤ 10μM |
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
390 |
0.24 |
Functional ≤ 10μM |
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
3 |
0.31 |
Functional ≤ 10μM
|
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
440 |
0.23 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.23 |
Functional ≤ 10μM |
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
1600 |
0.21 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z80571-1-O |
UCLA P-3 (cluster #1 Of 1), Other |
Other |
730 |
0.23 |
Functional ≤ 10μM |
Z80585-1-O |
WALKER (cluster #1 Of 1), Other |
Other |
47 |
0.27 |
Functional ≤ 10μM |
Z80606-1-O |
YOSHIDA (Sarcoma Cells) (cluster #1 Of 1), Other |
Other |
7 |
0.30 |
Functional ≤ 10μM |
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.26 |
Functional ≤ 10μM
|
Z80957-1-O |
HMEC (Microvascular Endothelial Cells) (cluster #1 Of 2), Other |
Other |
98 |
0.26 |
Functional ≤ 10μM |
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
7000 |
0.19 |
Functional ≤ 10μM |
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
700 |
0.23 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
380 |
0.24 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
83 |
0.26 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
640 |
0.23 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
16 |
0.29 |
Functional ≤ 10μM |
Z81159-1-O |
Lewis Cell Line (cluster #1 Of 1), Other |
Other |
61 |
0.27 |
Functional ≤ 10μM |
Z81227-1-O |
M-19 Cell Line (cluster #1 Of 1), Other |
Other |
2000 |
0.21 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
977 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
2960 |
0.20 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
250 |
0.24 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
8600 |
0.19 |
Functional ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
880 |
0.22 |
ADME/T ≤ 10μM |
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
2500 |
0.21 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.90 |
1.34 |
-54.26 |
7 |
11 |
1 |
187 |
528.534 |
4 |
↓
|
|
|
Analogs
-
3917708
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103196-1-O |
22RV1 (cluster #1 Of 2), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM |
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
2540 |
0.20 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
940 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
4700 |
0.19 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
950 |
0.22 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
430 |
0.23 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
17 |
0.28 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
680 |
0.22 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80640-1-O |
786-0 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
3100 |
0.20 |
Functional ≤ 10μM |
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
540 |
0.22 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
6810 |
0.19 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
1290 |
0.21 |
Functional ≤ 10μM |
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
710 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
840 |
0.22 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
2320 |
0.20 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.88 |
-58.15 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
-
3830631
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
AURKA-1-E |
Serine/threonine-protein Kinase Aurora-A (cluster #1 Of 3), Eukaryotic |
Eukaryotes |
40 |
0.27 |
Binding ≤ 10μM |
MMP2-2-E |
72 KDa Type IV Collagenase (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
1100 |
0.21 |
Binding ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1000 |
0.22 |
Binding ≤ 10μM
|
TOP1-1-E |
DNA Topoisomerase I (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2A-1-E |
DNA Topoisomerase II Alpha (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
TOP2B-1-E |
DNA Topoisomerase II Beta (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
22 |
0.27 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 2), Other |
Other |
2600 |
0.20 |
Binding ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
130 |
0.25 |
Functional ≤ 10μM
|
Z103205-1-O |
A431 (cluster #1 Of 4), Other |
Other |
370 |
0.23 |
Functional ≤ 10μM
|
Z103219-1-O |
Ca9-22 (cluster #1 Of 1), Other |
Other |
1300 |
0.21 |
Functional ≤ 10μM
|
Z50347-3-O |
Saccharomyces Cerevisiae (cluster #3 Of 3), Other |
Other |
10000 |
0.18 |
Functional ≤ 10μM
|
Z50587-4-O |
Homo Sapiens (cluster #4 Of 9), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z50643-2-O |
Hepatitis C Virus (cluster #2 Of 5), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80008-1-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80017-1-O |
A2780cisR (Cisplatin-resistant Ovarian Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80018-2-O |
A-375 (Malignant Melanoma Cells) (cluster #2 Of 4), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM |
Z80021-3-O |
A498 (Renal Carcinoma Cells) (cluster #3 Of 5), Other |
Other |
53 |
0.26 |
Functional ≤ 10μM
|
Z80025-1-O |
ACHN (Renal Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM |
Z80026-1-O |
AGS (Gastric Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
310 |
0.23 |
Functional ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 7), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z80039-1-O |
BGC-823 (Stomach Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80052-1-O |
C8166 (Leukemic T-cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80068-1-O |
CCRF-SB (Lymphoblastic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80088-1-O |
CHO (Ovarian Cells) (cluster #1 Of 4), Other |
Other |
6000 |
0.19 |
Functional ≤ 10μM
|
Z80092-1-O |
CHO-K1 (Ovarian Cells) (cluster #1 Of 2), Other |
Other |
400 |
0.23 |
Functional ≤ 10μM
|
Z80105-2-O |
COR-L23 (Lung Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
319 |
0.23 |
Functional ≤ 10μM
|
Z80114-1-O |
Daudi (Burkitts Lymphoma Cells) (cluster #1 Of 4), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z80125-1-O |
DU-145 (Prostate Carcinoma) (cluster #1 Of 9), Other |
Other |
6240 |
0.19 |
Functional ≤ 10μM |
Z80126-2-O |
DuPro (cluster #2 Of 2), Other |
Other |
1800 |
0.21 |
Functional ≤ 10μM
|
Z80138-1-O |
G-361 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80145-3-O |
H69 (cluster #3 Of 4), Other |
Other |
870 |
0.22 |
Functional ≤ 10μM
|
Z80156-2-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80164-1-O |
HT-1080 (Fibrosarcoma Cells) (cluster #1 Of 6), Other |
Other |
9320 |
0.18 |
Functional ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
92 |
0.25 |
Functional ≤ 10μM
|
Z80175-1-O |
IMR-32 (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80188-1-O |
KB 3-1 (Cervical Epithelial Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
21 |
0.28 |
Functional ≤ 10μM
|
Z80193-2-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #2 Of 12), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
9700 |
0.18 |
Functional ≤ 10μM
|
Z80214-2-O |
M14 (Melanoma Cells) (cluster #2 Of 3), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
920 |
0.22 |
Functional ≤ 10μM
|
Z80227-1-O |
MCF7-ADR (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
6700 |
0.19 |
Functional ≤ 10μM
|
Z80240-1-O |
MDA-MB-361 (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
Functional ≤ 10μM
|
Z80243-1-O |
MDA-MB-453 (Breast Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80244-4-O |
MDA-MB-468 (Breast Adenocarcinoma) (cluster #4 Of 7), Other |
Other |
7 |
0.29 |
Functional ≤ 10μM
|
Z80254-1-O |
MES-SA (Uterine Sarcoma Cells) (cluster #1 Of 2), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80255-2-O |
MES-SA/DxS (Uterine Sarcoma Cells) (cluster #2 Of 2), Other |
Other |
704 |
0.22 |
Functional ≤ 10μM
|
Z80267-1-O |
MKN-1 (cluster #1 Of 1), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80269-1-O |
MKN-45 (Gastric Adenocarcinoma Cells) (cluster #1 Of 3), Other |
Other |
3130 |
0.20 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80295-6-O |
MT4 (Lymphocytes) (cluster #6 Of 8), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM |
Z80322-2-O |
NCI-H358 (Lung Carcinama Cells) (cluster #2 Of 2), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z80330-1-O |
NCI-N87 (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
Functional ≤ 10μM
|
Z80354-4-O |
OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
830 |
0.22 |
Functional ≤ 10μM |
Z80364-1-O |
P388/ADR (Lymphoma Cells) (cluster #1 Of 1), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80367-1-O |
P388/S (cluster #1 Of 1), Other |
Other |
13 |
0.28 |
Functional ≤ 10μM
|
Z80389-1-O |
PC-14 (cluster #1 Of 1), Other |
Other |
290 |
0.23 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
912 |
0.22 |
Functional ≤ 10μM
|
Z80414-1-O |
Raji (B-lymphoblastic Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80433-1-O |
RPMI-8226 (Multiple Myeloma Cells) (cluster #1 Of 3), Other |
Other |
560 |
0.22 |
Functional ≤ 10μM
|
Z80441-1-O |
RXF 944 (cluster #1 Of 1), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80468-1-O |
SF-295 (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
35 |
0.27 |
Functional ≤ 10μM
|
Z80472-1-O |
SiHa (Cervical Squamous Cell Carcinoma) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80475-1-O |
SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80477-1-O |
SK_HEP1 (Hepatoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
Functional ≤ 10μM
|
Z80479-1-O |
SK-MEL (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
1730 |
0.21 |
Functional ≤ 10μM
|
Z80481-1-O |
SK-MEL-1 (Metastatic Melanoma Cells) (cluster #1 Of 1), Other |
Other |
3092 |
0.20 |
Functional ≤ 10μM |
Z80482-3-O |
SK-MEL-2 (Melanoma Cells) (cluster #3 Of 4), Other |
Other |
97 |
0.25 |
Functional ≤ 10μM
|
Z80485-1-O |
SK-MEL-28 (Melanoma Cells) (cluster #1 Of 6), Other |
Other |
600 |
0.22 |
Functional ≤ 10μM |
Z80490-3-O |
SK-MES-1 (cluster #3 Of 4), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80491-2-O |
SK-N-MC (Neuroepithelioma Cells) (cluster #2 Of 4), Other |
Other |
120 |
0.25 |
Functional ≤ 10μM
|
Z80492-1-O |
SK-N-SH (Neuroblastoma Cells) (cluster #1 Of 2), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z80493-1-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
800 |
0.22 |
Functional ≤ 10μM
|
Z80495-1-O |
SK-VLB (cluster #1 Of 1), Other |
Other |
6540 |
0.19 |
Functional ≤ 10μM
|
Z80503-1-O |
SNU1 (cluster #1 Of 2), Other |
Other |
4000 |
0.19 |
Functional ≤ 10μM
|
Z80509-1-O |
SNU-638 (Gastric Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
690 |
0.22 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM |
Z80532-1-O |
T-24 (Bladder Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
640 |
0.22 |
Functional ≤ 10μM
|
Z80559-1-O |
U251 (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80560-1-O |
U-251 (Glioma Cells) (cluster #1 Of 3), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80563-1-O |
U-373 MG ( Glioblastoma Cells) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80565-1-O |
U-87 MG (Glioblastoma Cells) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80574-2-O |
UMUC3 (cluster #2 Of 2), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80581-1-O |
VA13 (cluster #1 Of 1), Other |
Other |
699 |
0.22 |
Functional ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 7), Other |
Other |
5000 |
0.19 |
Functional ≤ 10μM
|
Z80595-1-O |
WIL2-NS (Lymphoblastoid Cells) (cluster #1 Of 2), Other |
Other |
200 |
0.24 |
Functional ≤ 10μM |
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
44 |
0.26 |
Functional ≤ 10μM
|
Z80608-1-O |
ZR-75-1 (Breast Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
9 |
0.29 |
Functional ≤ 10μM
|
Z80661-1-O |
A704 (Renal Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
2000 |
0.20 |
Functional ≤ 10μM
|
Z80682-1-O |
A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other |
Other |
970 |
0.22 |
Functional ≤ 10μM
|
Z80697-1-O |
Bel-7402 (Hepatoma Cells) (cluster #1 Of 3), Other |
Other |
1000 |
0.22 |
Functional ≤ 10μM
|
Z80712-2-O |
T47D (Breast Carcinoma Cells) (cluster #2 Of 7), Other |
Other |
72 |
0.26 |
Functional ≤ 10μM
|
Z80726-1-O |
TRAMP-C1A (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
76 |
0.26 |
Functional ≤ 10μM
|
Z80730-1-O |
C2D Cell Line (cluster #1 Of 1), Other |
Other |
47 |
0.26 |
Functional ≤ 10μM
|
Z80731-1-O |
C2G Cell Line (cluster #1 Of 1), Other |
Other |
29 |
0.27 |
Functional ≤ 10μM
|
Z80732-1-O |
TRAMP-C2H (Prostate Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80735-1-O |
C38 (Colon Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z80768-1-O |
CH1 (Ovarian Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
6 |
0.30 |
Functional ≤ 10μM
|
Z80784-1-O |
Col2 (Colon Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
520 |
0.23 |
Functional ≤ 10μM
|
Z80801-2-O |
CRL-7065 Cell Line (cluster #2 Of 2), Other |
Other |
500 |
0.23 |
Functional ≤ 10μM
|
Z80819-1-O |
J774.2 (cluster #1 Of 1), Other |
Other |
368 |
0.23 |
Functional ≤ 10μM |
Z80846-1-O |
F460pv8/eto Cell Line (cluster #1 Of 2), Other |
Other |
20 |
0.28 |
Functional ≤ 10μM
|
Z80852-1-O |
A-431 (Epidermoid Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
50 |
0.26 |
Functional ≤ 10μM
|
Z80874-1-O |
CEM (T-cell Leukemia) (cluster #1 Of 7), Other |
Other |
60 |
0.26 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
700 |
0.22 |
Functional ≤ 10μM
|
Z80889-1-O |
NCI-H322M (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z80896-1-O |
NCI-H69 (Small Cell Lung Carcinoma Cells) (cluster #1 Of 1), Other |
Other |
27 |
0.27 |
Functional ≤ 10μM
|
Z80928-1-O |
HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z80936-1-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #1 Of 4), Other |
Other |
900 |
0.22 |
Functional ≤ 10μM |
Z80943-1-O |
HEL 299 (cluster #1 Of 1), Other |
Other |
1700 |
0.21 |
Functional ≤ 10μM |
Z80945-1-O |
HEp-2 (Laryngeal Carcinoma Cells) (cluster #1 Of 4), Other |
Other |
59 |
0.26 |
Functional ≤ 10μM
|
Z81005-1-O |
HTB-54 Cell Line (cluster #1 Of 1), Other |
Other |
1100 |
0.21 |
Functional ≤ 10μM
|
Z81006-1-O |
Human Breast 401NL Tumor Cell Line (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81017-1-O |
WiDr (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
620 |
0.22 |
Functional ≤ 10μM
|
Z81020-3-O |
HepG2 (Hepatoblastoma Cells) (cluster #3 Of 8), Other |
Other |
954 |
0.22 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
660 |
0.22 |
Functional ≤ 10μM
|
Z81025-1-O |
Human Lung LXF 529L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
30 |
0.27 |
Functional ≤ 10μM
|
Z81026-1-O |
Human Lung LXF 629L Tumor Cell Line (cluster #1 Of 1), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81028-1-O |
Human Melanoma Cell Line (cluster #1 Of 1), Other |
Other |
280 |
0.24 |
Functional ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 10), Other |
Other |
10 |
0.29 |
Functional ≤ 10μM
|
Z81043-1-O |
N592 (cluster #1 Of 2), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81054-1-O |
SF-268 (Glioblastoma Cells) (cluster #1 Of 3), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
90 |
0.25 |
Functional ≤ 10μM
|
Z81101-1-O |
KBM-3 Cell Line (cluster #1 Of 1), Other |
Other |
26 |
0.27 |
Functional ≤ 10μM
|
Z81102-1-O |
KBM-3/DOX Cell Line (cluster #1 Of 1), Other |
Other |
490 |
0.23 |
Functional ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 6), Other |
Other |
7010 |
0.19 |
Functional ≤ 10μM
|
Z81133-1-O |
L1210 (1565) (cluster #1 Of 1), Other |
Other |
315 |
0.23 |
Functional ≤ 10μM |
Z81134-1-O |
L2987 (Lung Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
300 |
0.23 |
Functional ≤ 10μM
|
Z81160-1-O |
Lewis Lung Carcinoma Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81164-1-O |
LL Cell Line (cluster #1 Of 2), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81167-1-O |
LLTC Cell Line (cluster #1 Of 1), Other |
Other |
22 |
0.27 |
Functional ≤ 10μM
|
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
78 |
0.26 |
Functional ≤ 10μM
|
Z81184-1-O |
LOX IMVI (Melanoma Cells) (cluster #1 Of 5), Other |
Other |
42 |
0.26 |
Functional ≤ 10μM
|
Z81201-1-O |
HOP-62 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
4 |
0.30 |
Functional ≤ 10μM
|
Z81211-1-O |
LXFL529 Cell Line (cluster #1 Of 1), Other |
Other |
40 |
0.27 |
Functional ≤ 10μM
|
Z81244-1-O |
J774 (Macrophage Cells) (cluster #1 Of 1), Other |
Other |
79 |
0.25 |
Functional ≤ 10μM |
Z81245-1-O |
MDA-MB-435 (Breast Carcinoma Cells) (cluster #1 Of 6), Other |
Other |
960 |
0.22 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
730 |
0.22 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
70 |
0.26 |
Functional ≤ 10μM
|
Z81257-1-O |
MEL-AC Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.21 |
Functional ≤ 10μM
|
Z81261-1-O |
UACC-375 (cluster #1 Of 1), Other |
Other |
112 |
0.25 |
Functional ≤ 10μM
|
Z81277-2-O |
NCI-N417 (cluster #2 Of 2), Other |
Other |
230 |
0.24 |
Functional ≤ 10μM
|
Z81280-1-O |
NCI-H226 (Non-small Cell Lung Carcinoma Cells) (cluster #1 Of 3), Other |
Other |
8 |
0.29 |
Functional ≤ 10μM
|
Z81284-1-O |
NCI-H647 (cluster #1 Of 2), Other |
Other |
1 |
0.32 |
Functional ≤ 10μM
|
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
80 |
0.25 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
820 |
0.22 |
Functional ≤ 10μM
|
Z81341-1-O |
Tumor Cell Lines (cluster #1 Of 1), Other |
Other |
74 |
0.26 |
Functional ≤ 10μM
|
Z100081-1-O |
PBMC (Peripheral Blood Mononuclear Cells) (cluster #1 Of 2), Other |
Other |
500 |
0.23 |
ADME/T ≤ 10μM
|
Z80002-1-O |
1A9 (Ovarian Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80005-1-O |
3T3 (Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
3700 |
0.19 |
ADME/T ≤ 10μM
|
Z80035-1-O |
B16 (Melanoma Cells) (cluster #1 Of 1), Other |
Other |
100 |
0.25 |
ADME/T ≤ 10μM
|
Z80054-1-O |
Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
600 |
0.22 |
ADME/T ≤ 10μM |
Z80064-1-O |
CCRF-CEM (T-cell Leukemia) (cluster #1 Of 2), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 2), Other |
Other |
480 |
0.23 |
ADME/T ≤ 10μM
|
Z80178-2-O |
J774.A1 (Macrophage Cells) (cluster #2 Of 2), Other |
Other |
20 |
0.28 |
ADME/T ≤ 10μM |
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 3), Other |
Other |
60 |
0.26 |
ADME/T ≤ 10μM
|
Z80193-3-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #3 Of 4), Other |
Other |
29 |
0.27 |
ADME/T ≤ 10μM
|
Z80211-1-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #1 Of 1), Other |
Other |
33 |
0.27 |
ADME/T ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
70 |
0.26 |
ADME/T ≤ 10μM
|
Z80253-2-O |
MEF (Embryonic Fibroblast Cells) (cluster #2 Of 2), Other |
Other |
3400 |
0.20 |
ADME/T ≤ 10μM
|
Z80291-1-O |
MRC5 (Embryonic Lung Fibroblast Cells) (cluster #1 Of 3), Other |
Other |
300 |
0.23 |
ADME/T ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 2), Other |
Other |
2000 |
0.20 |
ADME/T ≤ 10μM
|
Z80548-2-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
8 |
0.29 |
ADME/T ≤ 10μM
|
Z80583-1-O |
Vero (Kidney Cells) (cluster #1 Of 3), Other |
Other |
7400 |
0.18 |
ADME/T ≤ 10μM
|
Z80682-2-O |
A549 (Lung Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
900 |
0.22 |
ADME/T ≤ 10μM
|
Z80704-1-O |
BJ (Foreskin Fibroblast Cells) (cluster #1 Of 2), Other |
Other |
2700 |
0.20 |
ADME/T ≤ 10μM
|
Z80936-4-O |
HEK293 (Embryonic Kidney Fibroblasts) (cluster #4 Of 4), Other |
Other |
64 |
0.26 |
ADME/T ≤ 10μM
|
Z81020-1-O |
HepG2 (Hepatoblastoma Cells) (cluster #1 Of 1), Other |
Other |
420 |
0.23 |
ADME/T ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 1), Other |
Other |
10 |
0.29 |
ADME/T ≤ 10μM
|
Z81034-2-O |
A2780 (Ovarian Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
7 |
0.29 |
ADME/T ≤ 10μM
|
Z81057-5-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #5 Of 5), Other |
Other |
30 |
0.27 |
ADME/T ≤ 10μM
|
Z81115-2-O |
KB (Squamous Cell Carcinoma) (cluster #2 Of 3), Other |
Other |
400 |
0.23 |
ADME/T ≤ 10μM
|
Z81331-2-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #2 Of 2), Other |
Other |
178 |
0.24 |
ADME/T ≤ 10μM
|
Q7ZJM1-1-V |
Human Immunodeficiency Virus Type 1 Integrase (cluster #1 Of 6), Viral |
Viruses |
900 |
0.22 |
Binding ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.57 |
-0.9 |
-63.19 |
8 |
12 |
1 |
208 |
544.533 |
5 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
RIPK1-1-E |
Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
182 |
0.52 |
Binding ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
490 |
0.49 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.66 |
6.08 |
-11.19 |
2 |
4 |
0 |
48 |
259.334 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 17 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
RIPK1-1-E |
Receptor-interacting Serine/threonine-protein Kinase 1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
182 |
0.52 |
Binding ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
490 |
0.49 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.66 |
6.11 |
-11.76 |
2 |
4 |
0 |
48 |
259.334 |
2 |
↓
|
|
|
Analogs
-
3647586
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
1300 |
0.46 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.12 |
-2.46 |
-9.5 |
2 |
5 |
0 |
65 |
243.266 |
2 |
↓
|
|
|
Analogs
-
3647584
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
1300 |
0.46 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
1.12 |
-2.34 |
-10.01 |
2 |
5 |
0 |
65 |
243.266 |
2 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z80548-1-O |
THP-1 (Acute Monocytic Leukemia Cells) (cluster #1 Of 5), Other |
Other |
270 |
0.23 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
25 |
0.27 |
Functional ≤ 10μM |
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.11 |
9.2 |
-51.89 |
3 |
10 |
-1 |
154 |
568.5 |
12 |
↓
|
|
|
Analogs
-
34527023
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Q862F3-2-E |
Tubulin Alpha Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
Q862L2-2-E |
Tubulin Alpha-1 Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
TBA1A-1-E |
Tubulin Alpha-1 Chain (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
3100 |
0.30 |
Functional ≤ 10μM
|
TBB2B-2-E |
Tubulin Beta Chain (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
2200 |
0.30 |
Functional ≤ 10μM
|
Z103203-1-O |
A375 (cluster #1 Of 3), Other |
Other |
1111 |
0.32 |
Functional ≤ 10μM |
Z80125-4-O |
DU-145 (Prostate Carcinoma) (cluster #4 Of 9), Other |
Other |
839 |
0.33 |
Functional ≤ 10μM |
Z80156-1-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #1 Of 12), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM
|
Z80362-1-O |
P388 (Lymphoma Cells) (cluster #1 Of 8), Other |
Other |
190 |
0.36 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
786 |
0.33 |
Functional ≤ 10μM |
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
960 |
0.32 |
Functional ≤ 10μM
|
Z81024-1-O |
NCI-H460 (Non-small Cell Lung Carcinoma) (cluster #1 Of 8), Other |
Other |
350 |
0.35 |
Functional ≤ 10μM
|
Z81034-1-O |
A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
170 |
0.36 |
Functional ≤ 10μM |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
160 |
0.37 |
Functional ≤ 10μM |
Z81170-1-O |
LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other |
Other |
658 |
0.33 |
Functional ≤ 10μM |
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
270 |
0.35 |
Functional ≤ 10μM |
Z81331-1-O |
SW-620 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
190 |
0.36 |
Functional ≤ 10μM |
Z81335-4-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #4 Of 5), Other |
Other |
340 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.33 |
3.28 |
-12.76 |
3 |
7 |
0 |
101 |
371.418 |
6 |
↓
|
Hi
High (pH 8-9.5)
|
3.33 |
3.22 |
-44.02 |
2 |
7 |
-1 |
103 |
370.41 |
6 |
↓
|
|
|
Analogs
-
4335036
-
-
4335037
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
5400 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.70 |
10.03 |
-8.4 |
0 |
3 |
0 |
33 |
308.356 |
1 |
↓
|
|
|
Analogs
-
3965914
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 36 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
DCLK3-1-E |
Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
JAK1-1-E |
Tyrosine-protein Kinase JAK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
6 |
0.50 |
Binding ≤ 10μM |
JAK2-1-E |
Tyrosine-protein Kinase JAK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
5 |
0.51 |
Binding ≤ 10μM
|
JAK3-2-E |
Tyrosine-protein Kinase JAK3 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
48 |
0.45 |
Binding ≤ 10μM |
KCC1A-1-E |
CaM Kinase I Alpha (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
5000 |
0.32 |
Binding ≤ 10μM
|
KS6A2-1-E |
Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
1400 |
0.36 |
Binding ≤ 10μM
|
KS6A6-1-E |
Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1200 |
0.36 |
Binding ≤ 10μM
|
LCK-1-E |
Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
3870 |
0.33 |
Binding ≤ 10μM
|
NUAK2-1-E |
NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
420 |
0.39 |
Binding ≤ 10μM
|
PKN1-1-E |
Protein Kinase N1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
200 |
0.41 |
Binding ≤ 10μM
|
ROCK2-2-E |
Rho-associated Protein Kinase 2 (cluster #2 Of 2), Eukaryotic |
Eukaryotes |
3400 |
0.33 |
Binding ≤ 10μM
|
STK3-1-E |
Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
4300 |
0.33 |
Binding ≤ 10μM
|
TNK1-1-E |
Non-receptor Tyrosine-protein Kinase TNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
640 |
0.38 |
Binding ≤ 10μM
|
TYK2-1-E |
Tyrosine-protein Kinase TYK2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
620 |
0.38 |
Binding ≤ 10μM
|
Z80036-1-O |
BaF3 (IL-3-dependent Pro-B-cells) (cluster #1 Of 3), Other |
Other |
570 |
0.38 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
7840 |
0.31 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.45 |
9.01 |
-25.29 |
1 |
7 |
0 |
89 |
312.377 |
3 |
↓
|
Mid
Mid (pH 6-8)
|
-0.01 |
6.74 |
-49.17 |
1 |
7 |
1 |
86 |
313.385 |
3 |
↓
|
Lo
Low (pH 4.5-6)
|
0.45 |
9.48 |
-43.37 |
2 |
7 |
1 |
90 |
313.385 |
3 |
↓
|
|
|
Analogs
-
4335040
-
-
4335041
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
840 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.59 |
1.56 |
-9.36 |
0 |
4 |
0 |
41 |
320.392 |
2 |
↓
|
|
|
|
|
Analogs
-
3995358
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
6400 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.62 |
1.53 |
-11.71 |
0 |
5 |
0 |
51 |
350.418 |
3 |
↓
|
|
|
|
|
Analogs
-
4957029
-
-
4957032
-
-
4006071
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
680 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.71 |
2.36 |
-11.93 |
0 |
4 |
0 |
41 |
338.382 |
2 |
↓
|
|
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
CDC7-1-E |
Cell Division Cycle 7-related Protein Kinase (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
10 |
0.70 |
Binding ≤ 10μM
|
CDK1-1-E |
Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic |
Eukaryotes |
250 |
0.58 |
Binding ≤ 10μM
|
CDK2-1-E |
Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic |
Eukaryotes |
240 |
0.58 |
Binding ≤ 10μM
|
CDK5-1-E |
Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
460 |
0.55 |
Binding ≤ 10μM
|
CDK9-1-E |
Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
34 |
0.65 |
Binding ≤ 10μM
|
CHK2-1-E |
Serine/threonine-protein Kinase Chk2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
1100 |
0.52 |
Binding ≤ 10μM
|
GSK3B-1-E |
Glycogen Synthase Kinase-3 Beta (cluster #1 Of 7), Eukaryotic |
Eukaryotes |
220 |
0.58 |
Binding ≤ 10μM
|
KS6A4-1-E |
Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
3010 |
0.48 |
Binding ≤ 10μM
|
KS6A5-2-E |
Ribosomal Protein S6 Kinase Alpha 5 (cluster #2 Of 3), Eukaryotic |
Eukaryotes |
2340 |
0.49 |
Binding ≤ 10μM
|
MAPK2-1-E |
MAP Kinase-activated Protein Kinase 2 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
470 |
0.55 |
Binding ≤ 10μM
|
MAPK5-1-E |
MAP Kinase-activated Protein Kinase 5 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
500 |
0.55 |
Binding ≤ 10μM
|
MKNK1-1-E |
MAP Kinase-interacting Serine/threonine-protein Kinase MNK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
2670 |
0.49 |
Binding ≤ 10μM
|
MKNK2-1-E |
MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic |
Eukaryotes |
171 |
0.59 |
Binding ≤ 10μM
|
PLK1-1-E |
Serine/threonine-protein Kinase PLK1 (cluster #1 Of 1), Eukaryotic |
Eukaryotes |
980 |
0.53 |
Binding ≤ 10μM
|
Z80166-1-O |
HT-29 (Colon Adenocarcinoma Cells) (cluster #1 Of 12), Other |
Other |
5000 |
0.46 |
Functional ≤ 10μM
|
Z80186-1-O |
K562 (Erythroleukemia Cells) (cluster #1 Of 11), Other |
Other |
5870 |
0.46 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
1330 |
0.51 |
Functional ≤ 10μM
|
Z80390-1-O |
PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other |
Other |
4590 |
0.47 |
Functional ≤ 10μM
|
Z80466-1-O |
SF268 (cluster #1 Of 4), Other |
Other |
860 |
0.53 |
Functional ≤ 10μM
|
Z80525-1-O |
SW48 (cluster #1 Of 2), Other |
Other |
1200 |
0.52 |
Functional ≤ 10μM
|
Z80526-1-O |
SW480 (Colon Adenocarcinoma Cells) (cluster #1 Of 6), Other |
Other |
2670 |
0.49 |
Functional ≤ 10μM
|
Z80561-1-O |
U2OS (Osteosarcoma Cells) (cluster #1 Of 1), Other |
Other |
1490 |
0.51 |
Functional ≤ 10μM
|
Z80928-3-O |
HCT-116 (Colon Carcinoma Cells) (cluster #3 Of 9), Other |
Other |
970 |
0.53 |
Functional ≤ 10μM
|
Z81034-3-O |
A2780 (Ovarian Carcinoma Cells) (cluster #3 Of 10), Other |
Other |
1100 |
0.52 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
3200 |
0.48 |
Functional ≤ 10μM
|
Z81247-1-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #1 Of 9), Other |
Other |
1830 |
0.50 |
Functional ≤ 10μM
|
Z81335-1-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #1 Of 5), Other |
Other |
3810 |
0.47 |
Functional ≤ 10μM
|
Z80335-1-O |
NHDF (cluster #1 Of 2), Other |
Other |
1600 |
0.51 |
ADME/T ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
0.64 |
2.58 |
-15.17 |
2 |
4 |
0 |
58 |
213.24 |
1 |
↓
|
Lo
Low (pH 4.5-6)
|
0.64 |
2.88 |
-44.62 |
3 |
4 |
1 |
59 |
214.248 |
1 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-7-O |
Jurkat (Acute Leukemic T-cells) (cluster #7 Of 10), Other |
Other |
3750 |
0.35 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.25 |
-7.6 |
-39.68 |
6 |
4 |
1 |
88 |
318.522 |
16 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Notice: Undefined index: field_name in /domains/zinc12/htdocs/lib/zinc/reporter/ZincAuxiliaryInfoReports.php on line 244
Notice: Undefined index: synonym in /domains/zinc12/htdocs/lib/zinc/reporter/ZincAuxiliaryInfoReports.php on line 245
Vendors
And 16 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-5-O |
Jurkat (Acute Leukemic T-cells) (cluster #5 Of 10), Other |
Other |
9000 |
0.47 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.40 |
6.37 |
-10.36 |
3 |
3 |
0 |
50 |
221.329 |
4 |
↓
|
|
|
|
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 5 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
6080 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.40 |
0.92 |
-10.83 |
0 |
4 |
0 |
44 |
382.51 |
4 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
150 |
0.34 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.82 |
10.31 |
-16.43 |
0 |
6 |
0 |
77 |
407.476 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
And 7 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
240 |
0.39 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.24 |
-0.23 |
-10.77 |
0 |
4 |
0 |
44 |
358.488 |
3 |
↓
|
|
|
Analogs
-
6056917
-
-
6056920
-
-
854229
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 3 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
1800 |
0.32 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.41 |
1.17 |
-12.11 |
0 |
4 |
0 |
58 |
367.499 |
3 |
↓
|
|
|
Analogs
-
6585237
-
-
6586815
-
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
8500 |
0.28 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
4.64 |
0.7 |
-11.15 |
0 |
4 |
0 |
58 |
387.917 |
3 |
↓
|
|
|
Analogs
Draw
Identity
99%
90%
80%
70%
Vendors
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
280 |
0.44 |
Functional ≤ 10μM
|
Z81072-1-O |
Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other |
Other |
400 |
0.43 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
3.25 |
6.76 |
-7.95 |
1 |
4 |
0 |
55 |
325.796 |
4 |
↓
|
|
|
Analogs
-
15449189
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
56 |
0.51 |
Functional ≤ 10μM
|
Z50426-3-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #3 Of 9), Other |
Other |
6 |
0.58 |
Functional ≤ 10μM
|
Z50436-3-O |
Filobasidiella Neoformans (cluster #3 Of 3), Other |
Other |
280 |
0.46 |
Functional ≤ 10μM
|
Z50442-2-O |
Candida Albicans (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 12), Other |
Other |
2900 |
0.39 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.43 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
850 |
0.42 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
540 |
0.44 |
Functional ≤ 10μM
|
Z80682-6-O |
A549 (Lung Carcinoma Cells) (cluster #6 Of 11), Other |
Other |
630 |
0.43 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 4), Other |
Other |
8910 |
0.35 |
Functional ≤ 10μM
|
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
650 |
0.43 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
460 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
3.29 |
-6.48 |
1 |
5 |
0 |
57 |
284.352 |
0 |
↓
|
|
|
Analogs
-
15449187
-
Draw
Identity
99%
90%
80%
70%
Vendors
And 1 More
Clustered Target Annotations
Code |
Organism Class |
Affinity (nM) |
LE (kcal/mol/atom) |
Type |
Z50425-1-O |
Plasmodium Falciparum (cluster #1 Of 22), Other |
Other |
56 |
0.51 |
Functional ≤ 10μM
|
Z50426-3-O |
Plasmodium Falciparum (isolate K1 / Thailand) (cluster #3 Of 9), Other |
Other |
6 |
0.58 |
Functional ≤ 10μM
|
Z50436-3-O |
Filobasidiella Neoformans (cluster #3 Of 3), Other |
Other |
280 |
0.46 |
Functional ≤ 10μM
|
Z50442-2-O |
Candida Albicans (cluster #2 Of 4), Other |
Other |
880 |
0.42 |
Functional ≤ 10μM
|
Z80156-3-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #3 Of 12), Other |
Other |
2900 |
0.39 |
Functional ≤ 10μM
|
Z80482-1-O |
SK-MEL-2 (Melanoma Cells) (cluster #1 Of 4), Other |
Other |
750 |
0.43 |
Functional ≤ 10μM
|
Z80493-2-O |
SK-OV-3 (Ovarian Carcinoma Cells) (cluster #2 Of 6), Other |
Other |
850 |
0.42 |
Functional ≤ 10μM
|
Z80600-2-O |
XF498 (Glioma Cells) (cluster #2 Of 2), Other |
Other |
540 |
0.44 |
Functional ≤ 10μM
|
Z80682-6-O |
A549 (Lung Carcinoma Cells) (cluster #6 Of 11), Other |
Other |
630 |
0.43 |
Functional ≤ 10μM
|
Z81057-2-O |
HUVEC (Umbilical Vein Endothelial Cells) (cluster #2 Of 4), Other |
Other |
8910 |
0.35 |
Functional ≤ 10μM
|
Z81072-2-O |
Jurkat (Acute Leukemic T-cells) (cluster #2 Of 10), Other |
Other |
650 |
0.43 |
Functional ≤ 10μM
|
Z81335-2-O |
HCT-15 (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
460 |
0.44 |
Functional ≤ 10μM
|
Physical Representations
Type
pH range
|
xlogP
|
Des A‑Pol
Apolar desolvation
(kcal/mol)
|
Des Pol
Polar desolvation
(kcal/mol)
|
H Don
H-bond donors
|
H Acc
H-bond acceptors
|
Chg
Net charge
|
tPSA
(Ų)
|
MWT
Molecular weight
(g/mol)
|
RB
Rotatable bonds
|
DL |
Ref
Reference (pH 7)
|
2.78 |
3.66 |
-6.09 |
1 |
5 |
0 |
57 |
284.352 |
0 |
↓
|
|